Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
|Articles|June 24, 2015
Trends in Pharmaceutical Capsules
ACG Worldwide discusses current and future uses of capsules in a video interview with Pharmaceutical Technology.
Advertisement
Ajit Singh, chairman of ACG Worldwide, spoke with Pharmaceutical Technology at INTERPHEX 2015 about trends in pharmaceutical capsules. Innovations include printing on the capsule as an anticounterfeiting measure and use of additional physical forms, such as liquids and pastes, inside capsules. In the future, large-molecule, biological products could be found in capsules, Singh predicts.
Advertisement
Related to this article
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
AI accountability, faster FDA pathways, rare disease CMC review, and next-gen GLP-1 formulation lead this week’s PharmTech roundup.
Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
2
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
3
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
4
Nitrosamine Problems and Industry Solutions: PharmTech Explained
5